Danaher Corporation (DHR) EV/Sales Ratio: 5.69x
Is Danaher Corporation’s EV/Sales ratio high or low?
Danaher Corporation's EV/Sales ratio of 5.69x is 19% below its 5-year average of 6.99x, near the low end of its 5-year range (5.16x–9.52x).
As of Monday, June 15, 2026. 14.05% below its 12-month average of 6.62x.
DHR EV/Sales Ratio Chart
DHR Average EV/Sales Ratio Chart
DHR Current vs Average EV/Sales Ratio Chart
DHR EV/Sales Ratio Metrics
EV/SALES RATIO
5.69x
EV/SALES RATIO AVG TTM
6.62x
EV/SALES RATIO AVG 3Y
7.16x
EV/SALES RATIO AVG 5Y
6.99x
EV/SALES RATIO AVG 10Y
5.91x
EV/SALES RATIO AVG 15Y
4.61x
EV/SALES RATIO AVG 20Y
3.87x
CURRENT VS TTM AVG
-14.05%
CURRENT VS 3Y AVG
-20.52%
CURRENT VS 5Y AVG
-18.65%
CURRENT VS 10Y AVG
-3.79%
CURRENT VS 15Y AVG
+23.55%
CURRENT VS 20Y AVG
+46.92%
DHR Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $127.47B | 5.69x | 6.62x | 7.16x | 6.99x |
| CVS Health Corporation (CVS)vs › | $130.09B | 0.49x | 0.44x | 0.43x | 0.51x |
| Bristol-Myers Squibb Company (BMY)vs › | $116.66B | 3.13x | 2.99x | 3.12x | 3.47x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $112.92B | 9.02x | 9.43x | 10.00x | 9.07x |
| Intuitive Surgical, Inc. (ISRG)vs › | $145.58B | 13.78x | 18.37x | 19.51x | 18.68x |
| Pfizer Inc. (PFE)vs › | $149.38B | 3.36x | 3.30x | 3.43x | 3.63x |
| Medtronic plc (MDT)vs › | $102.97B | 3.44x | 4.21x | 4.19x | 4.55x |
| Abbott Laboratories (ABT)vs › | $153.59B | 4.02x | 4.93x | 5.00x | 4.98x |
| Gilead Sciences, Inc. (GILD)vs › | $155.93B | 5.79x | 6.02x | 4.98x | 4.64x |
| Elevance Health Inc. (ELV)vs › | $87.75B | 0.56x | 0.51x | 0.67x | 0.76x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Danaher Corporation EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Danaher Corporation (DHR)?
- The EV/Sales ratio for DHR stock is 5.69x.
- Is Danaher Corporation's EV/Sales ratio high or low?
- Danaher Corporation's EV/Sales ratio of 5.69x is 19% below its 5-year average of 6.99x, near the low end of its 5-year range (5.16x–9.52x).
- What is the TTM average EV/Sales ratio for Danaher Corporation (DHR)?
- The TTM average EV/Sales ratio for DHR stock is 6.62x.
- What is the 3Y average EV/Sales ratio for Danaher Corporation (DHR)?
- The 3Y average EV/Sales ratio for DHR stock is 7.16x.
- What is the 5Y average EV/Sales ratio for Danaher Corporation (DHR)?
- The 5Y average EV/Sales ratio for DHR stock is 6.99x.
- What is the 10Y average EV/Sales ratio for Danaher Corporation (DHR)?
- The 10Y average EV/Sales ratio for DHR stock is 5.91x.
- What is the 15Y average EV/Sales ratio for Danaher Corporation (DHR)?
- The 15Y average EV/Sales ratio for DHR stock is 4.61x.
- What is the 20Y average EV/Sales ratio for Danaher Corporation (DHR)?
- The 20Y average EV/Sales ratio for DHR stock is 3.87x.
Danaher Corporation EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-12 | 5.69x |
| 2026-06-11 | 5.71x |
| 2026-06-10 | 5.79x |
| 2026-06-09 | 5.92x |
| 2026-06-08 | 5.78x |
| 2026-06-05 | 5.81x |
| 2026-06-04 | 5.87x |
| 2026-06-03 | 5.63x |
| 2026-06-02 | 5.57x |
| 2026-06-01 | 5.68x |
| 2026-05-29 | 5.76x |
| 2026-05-28 | 5.70x |
| 2026-05-27 | 5.49x |
| 2026-05-26 | 5.48x |
| 2026-05-22 | 5.45x |
| 2026-05-21 | 5.49x |
| 2026-05-20 | 5.43x |
| 2026-05-19 | 5.31x |
| 2026-05-18 | 5.22x |
| 2026-05-15 | 5.16x |
| 2026-05-14 | 5.24x |
| 2026-05-13 | 5.28x |
| 2026-05-12 | 5.29x |
| 2026-05-11 | 5.30x |
| 2026-05-08 | 5.43x |
| 2026-05-07 | 5.56x |
| 2026-05-06 | 5.54x |
| 2026-05-05 | 5.53x |
| 2026-05-04 | 5.51x |
| 2026-05-01 | 5.54x |
| 2026-04-30 | 5.65x |
| 2026-04-29 | 5.65x |
| 2026-04-28 | 5.65x |
| 2026-04-27 | 5.70x |
| 2026-04-24 | 5.60x |
| 2026-04-23 | 5.64x |
| 2026-04-22 | 5.80x |
| 2026-04-21 | 6.10x |
| 2026-04-20 | 6.13x |
| 2026-04-17 | 6.20x |
| 2026-04-16 | 6.17x |
| 2026-04-15 | 6.30x |
| 2026-04-14 | 6.31x |
| 2026-04-13 | 6.23x |
| 2026-04-10 | 6.05x |
| 2026-04-09 | 6.15x |
| 2026-04-08 | 6.24x |
| 2026-04-07 | 6.09x |
| 2026-04-06 | 6.12x |
| 2026-04-02 | 6.09x |
| 2026-04-01 | 6.08x |
| 2026-03-31 | 6.05x |
| 2026-03-30 | 5.88x |
| 2026-03-27 | 5.82x |
| 2026-03-26 | 6.00x |
| 2026-03-25 | 5.98x |
| 2026-03-24 | 6.06x |
| 2026-03-23 | 6.06x |
| 2026-03-20 | 6.04x |
| 2026-03-19 | 6.06x |
| 2026-03-18 | 6.10x |
| 2026-03-17 | 6.21x |
| 2026-03-16 | 6.10x |
| 2026-03-13 | 5.98x |
| 2026-03-12 | 5.95x |
| 2026-03-11 | 6.21x |
| 2026-03-10 | 6.21x |
| 2026-03-09 | 6.32x |
| 2026-03-06 | 6.22x |
| 2026-03-05 | 6.41x |
| 2026-03-04 | 6.49x |
| 2026-03-03 | 6.47x |
| 2026-03-02 | 6.52x |
| 2026-02-27 | 6.66x |
| 2026-02-26 | 6.62x |
| 2026-02-25 | 6.63x |
| 2026-02-24 | 6.62x |
| 2026-02-23 | 6.83x |
| 2026-02-20 | 6.79x |
| 2026-02-19 | 6.84x |
| 2026-02-18 | 6.77x |
| 2026-02-17 | 6.70x |
| 2026-02-13 | 6.88x |
| 2026-02-12 | 6.95x |
| 2026-02-11 | 7.10x |
| 2026-02-10 | 7.09x |
| 2026-02-09 | 7.00x |
| 2026-02-06 | 7.00x |
| 2026-02-05 | 6.98x |
| 2026-02-04 | 7.09x |
| 2026-02-03 | 7.00x |
| 2026-02-02 | 7.20x |
| 2026-01-30 | 7.07x |
| 2026-01-29 | 7.09x |
| 2026-01-28 | 7.24x |
| 2026-01-27 | 7.56x |
| 2026-01-26 | 7.59x |
| 2026-01-23 | 7.54x |
| 2026-01-22 | 7.69x |
| 2026-01-21 | 7.75x |
| 2026-01-20 | 7.52x |
| 2026-01-16 | 7.57x |
| 2026-01-15 | 7.69x |
| 2026-01-14 | 7.63x |
| 2026-01-13 | 7.56x |
| 2026-01-12 | 7.66x |
| 2026-01-09 | 7.64x |
| 2026-01-08 | 7.54x |
| 2026-01-07 | 7.56x |
| 2026-01-06 | 7.59x |
| 2026-01-05 | 7.55x |
| 2026-01-02 | 7.41x |
| 2025-12-31 | 7.36x |
| 2025-12-30 | 7.42x |
| 2025-12-29 | 7.41x |
| 2025-12-26 | 7.41x |
| 2025-12-24 | 7.44x |
| 2025-12-23 | 7.42x |
| 2025-12-22 | 7.34x |
| 2025-12-19 | 7.24x |
| 2025-12-18 | 7.23x |
| 2025-12-17 | 7.18x |
| 2025-12-16 | 7.24x |
| 2025-12-15 | 7.35x |
| 2025-12-12 | 7.29x |
| 2025-12-11 | 7.47x |
| 2025-12-10 | 7.41x |
| 2025-12-09 | 7.20x |
| 2025-12-08 | 7.23x |
| 2025-12-05 | 7.29x |
| 2025-12-04 | 7.31x |
| 2025-12-03 | 7.35x |
| 2025-12-02 | 7.30x |
| 2025-12-01 | 7.22x |
| 2025-11-28 | 7.30x |
| 2025-11-26 | 7.35x |
| 2025-11-25 | 7.42x |
| 2025-11-24 | 7.31x |
| 2025-11-21 | 7.32x |
| 2025-11-20 | 7.17x |
| 2025-11-19 | 7.17x |
| 2025-11-18 | 7.26x |
| 2025-11-17 | 7.11x |
| 2025-11-14 | 7.14x |
| 2025-11-13 | 7.14x |
| 2025-11-12 | 7.08x |
| 2025-11-11 | 6.98x |
| 2025-11-10 | 6.84x |
| 2025-11-07 | 6.81x |
| 2025-11-06 | 6.83x |
| 2025-11-05 | 6.87x |
| 2025-11-04 | 6.92x |
| 2025-11-03 | 6.93x |
| 2025-10-31 | 6.97x |
| 2025-10-30 | 6.96x |
| 2025-10-29 | 6.93x |
| 2025-10-28 | 7.01x |
| 2025-10-27 | 7.13x |
| 2025-10-24 | 7.19x |
| 2025-10-23 | 7.18x |
| 2025-10-22 | 7.05x |
| 2025-10-21 | 7.12x |
| 2025-10-20 | 6.76x |
| 2025-10-17 | 6.91x |
| 2025-10-16 | 6.97x |
| 2025-10-15 | 6.82x |
| 2025-10-14 | 6.82x |
| 2025-10-13 | 6.79x |
| 2025-10-10 | 6.71x |
| 2025-10-09 | 6.77x |
| 2025-10-08 | 6.79x |
| 2025-10-07 | 6.90x |
| 2025-10-06 | 6.99x |
| 2025-10-03 | 7.09x |
| 2025-10-02 | 6.95x |
| 2025-10-01 | 7.02x |
| 2025-09-30 | 6.59x |
| 2025-09-29 | 6.22x |
| 2025-09-26 | 6.18x |
| 2025-09-25 | 6.08x |
| 2025-09-24 | 6.22x |
| 2025-09-23 | 6.33x |
| 2025-09-22 | 6.35x |
| 2025-09-19 | 6.44x |
| 2025-09-18 | 6.50x |
| 2025-09-17 | 6.43x |
| 2025-09-16 | 6.35x |
| 2025-09-15 | 6.30x |
| 2025-09-12 | 6.34x |
| 2025-09-11 | 6.49x |
| 2025-09-10 | 6.42x |
| 2025-09-09 | 6.47x |
| 2025-09-08 | 6.60x |
| 2025-09-05 | 6.65x |
| 2025-09-04 | 6.61x |
| 2025-09-03 | 6.62x |
| 2025-09-02 | 6.75x |
| 2025-08-29 | 6.81x |
| 2025-08-28 | 6.80x |
| 2025-08-27 | 6.79x |
| 2025-08-26 | 6.83x |
| 2025-08-25 | 6.87x |
| 2025-08-22 | 6.99x |
| 2025-08-21 | 6.76x |
| 2025-08-20 | 6.98x |
| 2025-08-19 | 7.00x |
| 2025-08-18 | 6.91x |
| 2025-08-15 | 6.97x |
| 2025-08-14 | 6.94x |
| 2025-08-13 | 6.91x |
| 2025-08-12 | 6.81x |
| 2025-08-11 | 6.63x |
| 2025-08-08 | 6.66x |
| 2025-08-07 | 6.59x |
| 2025-08-06 | 6.49x |
| 2025-08-05 | 6.61x |
| 2025-08-04 | 6.56x |
| 2025-08-01 | 6.55x |
| 2025-07-31 | 6.55x |
| 2025-07-30 | 6.76x |
| 2025-07-29 | 6.84x |
| 2025-07-28 | 6.73x |
| 2025-07-25 | 6.80x |
| 2025-07-24 | 6.72x |
| 2025-07-23 | 6.58x |
| 2025-07-22 | 6.34x |
| 2025-07-21 | 6.28x |
| 2025-07-18 | 6.41x |
| 2025-07-17 | 6.55x |
| 2025-07-16 | 6.50x |
| 2025-07-15 | 6.49x |
| 2025-07-14 | 6.64x |
| 2025-07-11 | 6.85x |
| 2025-07-10 | 6.87x |
| 2025-07-09 | 6.74x |
| 2025-07-08 | 6.73x |
| 2025-07-07 | 6.70x |
| 2025-07-03 | 6.80x |
| 2025-07-02 | 6.78x |
| 2025-07-01 | 6.74x |
| 2025-06-30 | 6.63x |
| 2025-06-27 | 6.67x |
| 2025-06-26 | 6.75x |
| 2025-06-25 | 6.74x |
| 2025-06-24 | 6.63x |
| 2025-06-23 | 6.60x |
| 2025-06-20 | 6.60x |
| 2025-06-18 | 6.54x |
| 2025-06-17 | 6.58x |
| 2025-06-16 | 6.74x |
| 2025-06-13 | 6.73x |
| 2025-06-12 | 6.86x |
| 2025-06-11 | 6.85x |
| 2025-06-10 | 6.79x |
| 2025-06-09 | 6.68x |
| 2025-06-06 | 6.59x |
| 2025-06-05 | 6.47x |
| 2025-06-04 | 6.50x |
| 2025-06-03 | 6.47x |
| 2025-06-02 | 6.38x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair